|
DONGGUAN, China, Dec. 8, 2025 /PRNewswire/ -- PT Fapon Bioindustries Indonesia (referred to as "PT Fapon") and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) (referred to as "Bio Farma") officially signed a cooperation agreement at Fapon's headquarters in Dongguan. The partnership is centered on the local manufacturing, and commercialization of IVD products in Indonesia.
Mrs. Dyah, Chief Executive Officer of Fapon Indonesia Market, and Mr. Dicky, Head of the Business Development Division at Bio Farma, formally executed the agreement on behalf of their respective organizations. This collaboration represents a major advancement in localizing diagnostic technologies and upgrading Indonesia's healthcare industry.
Mrs. Dyah, CEO of Fapon Indonesia Market (right), and Mr. Dicky, Head of Business Development at Bio Farma (left), during the signing ceremony.
"We are excited to strengthen our partnership with PT Fapon to localize the production of high-end IVD products in Indonesia," said Mr. Shadiq Akasya, President Director of Bio Farma. "This collaboration will bolster our national capabilities in medical device manufacturing, thereby enabling broader disease detection coverage across Indonesia."
Mr. Ben He, President of Fapon Biotech, stated, "PT Fapon is deeply committed to fostering the growth of Indonesia's healthcare industry through meaningful technology partnerships. We are confident that this technology transfer and localization project will provide Indonesia with cutting-edge diagnostic solutions, and help build a more resilient and sustainable healthcare future."
PT Fapon is Fapon Group's first overseas manufacturing base, dedicated to supplying the Indonesian and regional markets with diagnostic products and solutions that meet international standards. Bio Farma, with a legacy spanning over 130 years, is a leading national life science enterprise in Indonesia, boasting extensive expertise in the research, development, production, and distribution of vaccines, biologics, and pharmaceutical products.
This partnership marks a significant milestone in PT Fapon's strategy to deepen its local roots and empower the autonomous development of Indonesia's medical industry. Looking ahead, both parties plan to explore further collaborative opportunities in medical innovation and technology transferring, jointly driving progress in healthcare across Indonesia and Southeast Asia.
About PT Fapon Bioindustries Indonesia
PT Fapon Bioindustries Indonesia, located in West Java, is Fapon's first international manufacturing base. The facility is built and operated in strict compliance with ISO 14644 standards and is dedicated to delivering high-quality in-vitro diagnostic (IVD) products and solutions to the Indonesian market. Leveraging the Fapon Group's global R&D, manufacturing, and service network, PT Fapon actively introduces advanced diagnostic technologies to support the growth of Indonesia's local healthcare industry, improve diagnostic accessibility, and contribute to enhancing public health in the country.
About PT Bio Farma (Persero)
PT Bio Farma (Persero) is a world-class, globally competitive life science company that has a role to provide and develop international standard life science products to improve the quality of life. Supported by competence, experience and learning process for more than 130 years, Bio Farma is present as part of the struggle to save and improve the quality of human life. Given the important role in building the nation's health, Bio Farma's existence is maintained from time to time.
DONGGUAN, China, Dec. 8, 2025 /PRNewswire/ -- PT Fapon Bioindustries Indonesia (referred to as "PT Fapon") and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) (referred to as "Bio Farma") officially signed a cooperation agreement at Fapon's headquarters in Dongguan. The partnership is centered on the local manufacturing, and commercialization of IVD products in Indonesia.
Mrs. Dyah, Chief Executive Officer of Fapon Indonesia Market, and Mr. Dicky, Head of the Business Development Division at Bio Farma, formally executed the agreement on behalf of their respective organizations. This collaboration represents a major advancement in localizing diagnostic technologies and upgrading Indonesia's healthcare industry.
Mrs. Dyah, CEO of Fapon Indonesia Market (right), and Mr. Dicky, Head of Business Development at Bio Farma (left), during the signing ceremony.
"We are excited to strengthen our partnership with PT Fapon to localize the production of high-end IVD products in Indonesia," said Mr. Shadiq Akasya, President Director of Bio Farma. "This collaboration will bolster our national capabilities in medical device manufacturing, thereby enabling broader disease detection coverage across Indonesia."
Mr. Ben He, President of Fapon Biotech, stated, "PT Fapon is deeply committed to fostering the growth of Indonesia's healthcare industry through meaningful technology partnerships. We are confident that this technology transfer and localization project will provide Indonesia with cutting-edge diagnostic solutions, and help build a more resilient and sustainable healthcare future."
PT Fapon is Fapon Group's first overseas manufacturing base, dedicated to supplying the Indonesian and regional markets with diagnostic products and solutions that meet international standards. Bio Farma, with a legacy spanning over 130 years, is a leading national life science enterprise in Indonesia, boasting extensive expertise in the research, development, production, and distribution of vaccines, biologics, and pharmaceutical products.
This partnership marks a significant milestone in PT Fapon's strategy to deepen its local roots and empower the autonomous development of Indonesia's medical industry. Looking ahead, both parties plan to explore further collaborative opportunities in medical innovation and technology transferring, jointly driving progress in healthcare across Indonesia and Southeast Asia.
About PT Fapon Bioindustries Indonesia
PT Fapon Bioindustries Indonesia, located in West Java, is Fapon's first international manufacturing base. The facility is built and operated in strict compliance with ISO 14644 standards and is dedicated to delivering high-quality in-vitro diagnostic (IVD) products and solutions to the Indonesian market. Leveraging the Fapon Group's global R&D, manufacturing, and service network, PT Fapon actively introduces advanced diagnostic technologies to support the growth of Indonesia's local healthcare industry, improve diagnostic accessibility, and contribute to enhancing public health in the country.
About PT Bio Farma (Persero)
PT Bio Farma (Persero) is a world-class, globally competitive life science company that has a role to provide and develop international standard life science products to improve the quality of life. Supported by competence, experience and learning process for more than 130 years, Bio Farma is present as part of the struggle to save and improve the quality of human life. Given the important role in building the nation's health, Bio Farma's existence is maintained from time to time.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
PT Fapon and PT Bio Farma Forge Strategic Partnership to Advance IVD Localization and Innovation in Indonesia
NEW YORK, March 4, 2026 /PRNewswire/ -- isinwheel, a leading innovator in electric mobility solutions, has launched its spring promotion and new product presales across the United States, running from February 27 to March 26, 2026, just as rising spring temperatures bring a return to outdoor travel and rider demand continues to grow for improved performance, safety, range, and adaptability across different riding scenarios.
During the spring season, users increasingly rely on electric scooters for daily commuting, recreational riding, and outdoor exploration. isinwheel continues to address these evolving needs through technology upgrades and an expanded product lineup through the introduction of two new off-road models while offering seasonal savings across its existing range.
As part of the spring campaign, isinwheel has announced presales for two new electric scooters designed for higher performance and broader riding conditions.
The GT1 Dual Off-Road Electric Scooter enters presale on March 10, with official sales beginning March 20. The upgraded model features 10-inch tires, a 48V 13Ah battery, and dual motors with peak power of 800W each, delivering a top speed of up to 32mph and a maximum range of up to 50 kilometers (31 miles). Customers who purchase either model during the presale period will receive exclusive launch benefits, including a scooter lock, storage bag, and a two-year extended warranty.
The spring promotion offers savings on several established models that cover riding needs from city commuting to off-road use, helping users start their riding season with greater peace of mind.
The S Nova Pro Commuter Scooter delivers up to 1000W of peak power, a top speed of 28mph, and a maximum range of 38 miles, supported by 10-inch pneumatic tires, making it an ideal choice of electric scooter for beginners. The GT2 Off-Road Electric Scooter offers a 1000W rated motor, 28mph top speed, 37 miles of range, and 11-inch off-road pneumatic tires. For more demanding conditions, the GT4 Off-Road Electric Scooter features dual 1200W motors, a top speed of up to 45mph, a maximum range of 50 miles, and 12-inch off-road tires.
During the campaign, customers who purchase two products receive an additional 10% discount, which can be combined with a spin-wheel promotion offering up to 10% additional savings. isinwheel members can earn five times the reward points, redeemable for accessories. An exclusive press release discount code, PR30, provides additional $30 off during the spring promotion period. The combination of new product launches and seasonal promotions is designed to help riders choose equipment that fits their commuting and outdoor travel needs as the new riding season begins.
About isinwheel
isinwheel is a global leader in the manufacture of personal E-scooters, committed to enhancing the riding experience through continuous innovation. Embracing the principles of sustainable development, isinwheel offers convenient, eco-friendly, stylish, and affordable transportation solutions. Bringing desired destinations closer, isinwheel enriches lives in simpler, more affordable, and enjoyable ways.
For more information, please visit isinwheel's website and social media:
Website: https://www.isinwheel.com
Instagram: https://www.instagram.com/isinwheel_global/
YouTube: https://www.youtube.com/isinwheel
Facebook: https://www.facebook.com/isinwheel.fans
X: https://twitter.com/isinwheelglobal
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
isinwheel Launches Spring Promotion and New Product Presales to Support New Season of Electric Scooter Riding in U.S.
